Diabetes Care Devices - NAFTA | Statista Market Forecast

Revenue in the Diabetes Care Devices market market in the North American Free Trade Agreement (in North American Free Trade Agreement (NAFTA)) region is projected to reach US$12.67bn in 2024.
This revenue is anticipated to exhibit an annual growth rate (CAGR 2024-2029) of 11.63%, leading to a market volume of US$21.96bn by 2029.
In a global context, the majority of this revenue will be generated the United States, which is expected to account for US$11.71bn in 2024.
In the United States, the Diabetes Care Devices market is increasingly integrating advanced digital health technologies to enhance patient management and self-monitoring capabilities.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market within the Medical Devices sector is witnessing considerable growth in the NAFTA region, fueled by increasing diabetes prevalence, technological advancements, and heightened consumer awareness regarding disease management.

Customer preferences: Consumers are increasingly prioritizing personalized diabetes care solutions that cater to their unique lifestyles and preferences, resulting in a growing demand for smart insulin pens and continuous glucose monitors that offer real-time data. Additionally, the rise of telehealth services is transforming how individuals manage their diabetes, enabling more frequent interactions with healthcare providers. This shift reflects a broader trend towards integrated health management, where technology plays a crucial role in enhancing patient engagement and self-management strategies.

Trends in the market: In North America, the Diabetes Care Devices Market is experiencing a surge in demand for smart insulin pens and continuous glucose monitors, as consumers seek personalized solutions that align with their lifestyles. In Mexico, there is an increasing adoption of telehealth services, facilitating remote consultations and improving access to diabetes management resources. Meanwhile, in Canada, integrated health management platforms are emerging, enabling seamless communication between patients and healthcare providers. These trends underscore the significance of technology in enhancing patient engagement and self-management, ultimately shaping the future landscape of diabetes care.

Local special circumstances: In the United States, the Diabetes Care Devices Market is propelled by a strong emphasis on innovation and consumer-driven healthcare, where patients demand advanced monitoring solutions that integrate with their daily lives. The regulatory environment, characterized by rigorous FDA approvals, ensures high safety standards, fostering confidence in new technologies. In contrast, in Mexico, cultural factors such as community support and family involvement in health decisions enhance the adoption of diabetes management devices, while government initiatives promote affordability and accessibility. Canada’s universal healthcare system supports the integration of diabetes technologies, encouraging holistic patient management and collaboration among healthcare providers.

Underlying macroeconomic factors: The Diabetes Care Devices Market is influenced by several macroeconomic factors, including global economic conditions, national healthcare expenditure, and fiscal policies. In the U.S., a robust economy drives investment in innovative diabetes technologies, supported by government funding for research and development. Conversely, Mexico's market is shaped by economic challenges that necessitate affordable solutions, prompting government initiatives to enhance healthcare access. Canada benefits from stable economic growth and fiscal policies that promote public health funding, facilitating the adoption of advanced diabetes management devices. Collectively, these factors shape market dynamics and innovation in diabetes care across North America.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.